These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28401768)

  • 1. Primary progressive multiple sclerosis presenting with severe predominant cognitive impairment and psychiatric symptoms: A challenging case.
    Zambon AA; Cecchetti G; Caso F; Santangelo R; Baldoli C; Natali Sora MG; Comi G; Magnani G; Martinelli V
    Mult Scler; 2017 Oct; 23(11):1558-1561. PubMed ID: 28401768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis.
    D'Ambrosio A; Pagani E; Riccitelli GC; Colombo B; Rodegher M; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2017 Aug; 23(9):1194-1203. PubMed ID: 27760859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom.
    Cortese M; Riise T; Bjørnevik K; Bhan A; Farbu E; Grytten N; Hogenesch I; Midgard R; Smith Simonsen C; Telstad W; Ascherio A; Myhr KM
    Ann Neurol; 2016 Oct; 80(4):616-24. PubMed ID: 27554176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of primary progressive multiple sclerosis with onset of memory impairment].
    Yamashita K; Nomura T; Ohyagi Y; Taniwaki T; Furuya H; Kuwabara Y; Kira J
    Rinsho Shinkeigaku; 2005 May; 45(5):351-6. PubMed ID: 15960171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.
    Kizlaitienė R; Kaubrys G; Giedraitienė N; Ramanauskas N; Dementavičienė J
    Med Sci Monit; 2017 Feb; 23():588-597. PubMed ID: 28145395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel fMRI working memory paradigm accurately detects cognitive impairment in multiple sclerosis.
    Nelson F; Akhtar MA; Zúñiga E; Perez CA; Hasan KM; Wilken J; Wolinsky JS; Narayana PA; Steinberg JL
    Mult Scler; 2017 May; 23(6):836-847. PubMed ID: 27613119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment.
    Müller S; Saur R; Greve B; Melms A; Hautzinger M; Fallgatter AJ; Leyhe T
    Mult Scler; 2013 May; 19(6):799-805. PubMed ID: 23166118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive visual function impairment as the predominant symptom of the transition phase to secondary progressive multiple sclerosis: A case report.
    Giordano A; Colombo B; Spinelli EG; Gelibter S; Guerrieri S; Leocani L; Comi G; Martinelli V
    Mult Scler Relat Disord; 2018 Aug; 24():69-71. PubMed ID: 29957351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Social Cognition and traditional cognitive impairment in Progressive Multiple Sclerosis and possible implicated neuroanatomical regions.
    Ciampi E; Uribe-San-Martin R; Vásquez M; Ruiz-Tagle A; Labbe T; Cruz JP; Lillo P; Slachevsky A; Reyes D; Reyes A; Cárcamo-Rodríguez C
    Mult Scler Relat Disord; 2018 Feb; 20():122-128. PubMed ID: 29414284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and cognitive correlates of fatigue in progressive multiple sclerosis.
    Andreasen AK; Iversen P; Marstrand L; Siersma V; Siebner HR; Sellebjerg F
    Neurol Res; 2019 Feb; 41(2):168-176. PubMed ID: 30513278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter tract abnormalities are associated with cognitive dysfunction in secondary progressive multiple sclerosis.
    Meijer KA; Muhlert N; Cercignani M; Sethi V; Ron MA; Thompson AJ; Miller DH; Chard D; Geurts JJ; Ciccarelli O
    Mult Scler; 2016 Oct; 22(11):1429-1437. PubMed ID: 26733423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis.
    Penny S; Khaleeli Z; Cipolotti L; Thompson A; Ron M
    Neurology; 2010 Feb; 74(7):545-52. PubMed ID: 20157157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic dilemma of multiple sclerosis presenting with isolated cognitive and behavioral disorders.
    Amato MP
    Mult Scler; 2017 Oct; 23(11):1561-1563. PubMed ID: 28401769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of primary progressive multiple sclerosis with improvement in cognitive impairment by anti-CD20 monoclonal antibody therapy].
    Onoue H; Kato Y; Ishido H; Ogawa T; Akaiwa Y; Miyamoto T
    Rinsho Shinkeigaku; 2023 Mar; 63(3):152-158. PubMed ID: 36843088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 years.
    McDonnell GV; Cabrera-Gomez J; Calne DB; Li DK; Oger J
    Mult Scler; 2003 Mar; 9(2):204-9. PubMed ID: 12708816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial.
    Chan D; Binks S; Nicholas JM; Frost C; Cardoso MJ; Ourselin S; Wilkie D; Nicholas R; Chataway J
    Lancet Neurol; 2017 Aug; 16(8):591-600. PubMed ID: 28600189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
    Ruano L; Portaccio E; Goretti B; Niccolai C; Severo M; Patti F; Cilia S; Gallo P; Grossi P; Ghezzi A; Roscio M; Mattioli F; Stampatori C; Trojano M; Viterbo RG; Amato MP
    Mult Scler; 2017 Aug; 23(9):1258-1267. PubMed ID: 27738090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: Treatment of cognitive impairment in secondary progressive MS.
    Feinstein A
    Nat Rev Neurol; 2017 Sep; 13(9):515-516. PubMed ID: 28752856
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinct cognitive impairments in different disease courses of multiple sclerosis-A systematic review and meta-analysis.
    Johnen A; Landmeyer NC; Bürkner PC; Wiendl H; Meuth SG; Holling H
    Neurosci Biobehav Rev; 2017 Dec; 83():568-578. PubMed ID: 28890199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cheiromegaly and podomegaly associated with primary progressive multiple sclerosis: a case report].
    Mutsukura K; Ouma S; Sakata S; Nakajima M; Tsuboi Y; Yamada T
    No To Shinkei; 2003 Dec; 55(12):1047-51. PubMed ID: 14870575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.